FDA officials question safety of antibiotic ‘Ketek’
Thursday, July 20, 2006 The New York Times reports that safety officials working for the Food and Drug Administration have expressed concerns over the safety of an antibiotic, telithromycin and questioned its approval for use. The drug, marketed under the trade name Ketek, has been widely prescribed since its 2004 FDA approval. The New York Times reports that David Graham, one of four FDA safety officials concerned about safety of the antibiotic in both adultsContinue reading